MacroGenics
MGNX
112 hedge funds and large institutions have $58.5M invested in MacroGenics in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 42 closing their positions.
66% more call options, than puts
Call options by funds: $83K | Put options by funds: $50K
8.72% less ownership
Funds ownership: 85.32% → 76.6% (-8.7%)
13% less funds holding
Funds holding: 128 → 112 (-16)
14% less capital invested
Capital invested by funds: $68.3M → $58.5M (-$9.82M)
26% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 35
38% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.32M |
| 2 |
Jane Street
New York
|
+$742K |
| 3 |
Goldman Sachs
New York
|
+$726K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$511K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$492K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.49M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.61M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.45M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.12M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$570K |
MGNX Hedge Fund Activity: Q2 2025 in Review
112 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2025, worth a combined $58.5M — down 14% from $68.3M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of MGNX and 26 opened new positions — a net loss of 16 holders — while 35 trimmed existing stakes and 26 added.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $2.32M. The largest seller was BlackRock, cutting an estimated $4.49M.
- 112 institutional investors held MacroGenics (MGNX) as of Q2 2025, down from 128 in Q1 2025.
- Funds reported $58.5M of MacroGenics stock for Q2 2025, down 14% quarter-over-quarter.
- 26 funds opened new MacroGenics positions in Q2 2025 and 42 closed out, a net change of -16 holders.
- The largest MacroGenics buyer in Q2 2025 was EcoR1 Capital, an estimated $2.32M added.
- The largest MacroGenics seller in Q2 2025 was BlackRock, an estimated $4.49M sold.
Based on aggregated 13F filings for Q2 2025.